The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pharmaceutical Traceability-Global Market Insights and Sales Trends 2025

Pharmaceutical Traceability-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1851236

No of Pages : 114

Synopsis

Pharmaceutical traceability deals with tracking and tracing a drug's history, location, and application at any point in the supply chain.

The global Pharmaceutical Traceability market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Traceability in various end use industries. The expanding demands from the Pharmaceutical Factory, Pharmacy, Hospital and Other, are propelling Pharmaceutical Traceability market. Barcode, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radio Frequency Identification (RFID) segment is estimated at % CAGR for the next seven-year period.

The growing concern towards drug counterfeit and theft to be one of the primary growth factors for the pharmaceutical traceability market.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Traceability, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pharmaceutical Traceability market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Pharmaceutical Traceability market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Traceability sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Pharmaceutical Traceability covered in this report include Avery Dennison, Cognex, Datalogic, Impinj, Zebra Technologies, Adents, Alien Technology, AlpVision and Atlantic Zeiser, etc.

The global Pharmaceutical Traceability market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Avery Dennison
  • Cognex
  • Datalogic
  • Impinj
  • Zebra Technologies
  • Adents
  • Alien Technology
  • AlpVision
  • Atlantic Zeiser
  • Authentix
  • Axway
  • Bar Code Integrators
  • SATO VICINITY
  • SMARTRAC
  • TraceLink

Global Pharmaceutical Traceability market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Pharmaceutical Traceability market, Segment by Type:

  • Barcode
  • Radio Frequency Identification (RFID)
  • Global Positioning System (GPS)

Global Pharmaceutical Traceability market, by Application

  • Pharmaceutical Factory
  • Pharmacy
  • Hospital
  • Other

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Traceability companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Pharmaceutical Traceability
1.1 Pharmaceutical Traceability Market Overview
1.1.1 Pharmaceutical Traceability Product Scope
1.1.2 Pharmaceutical Traceability Market Status and Outlook
1.2 Global Pharmaceutical Traceability Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Traceability Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Traceability Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Traceability Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Traceability Market Size (2018-2029)
1.6.1 North America Pharmaceutical Traceability Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Traceability Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Traceability Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Traceability Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Traceability Market Size (2018-2029)
2 Pharmaceutical Traceability Market by Type
2.1 Introduction
2.1.1 Barcode
2.1.2 Radio Frequency Identification (RFID)
2.1.3 Global Positioning System (GPS)
2.2 Global Pharmaceutical Traceability Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Traceability Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Traceability Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Traceability Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Traceability Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Traceability Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Traceability Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Traceability Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Traceability Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Factory
3.1.2 Pharmacy
3.1.3 Hospital
3.1.4 Other
3.2 Global Pharmaceutical Traceability Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Traceability Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Traceability Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Traceability Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Traceability Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Traceability Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Traceability Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Traceability Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Traceability Competition Analysis by Players
4.1 Global Pharmaceutical Traceability Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Traceability as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Traceability Market
4.4 Global Top Players Pharmaceutical Traceability Headquarters and Area Served
4.5 Key Players Pharmaceutical Traceability Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Traceability Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Avery Dennison
5.1.1 Avery Dennison Profile
5.1.2 Avery Dennison Main Business
5.1.3 Avery Dennison Pharmaceutical Traceability Products, Services and Solutions
5.1.4 Avery Dennison Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.1.5 Avery Dennison Recent Developments
5.2 Cognex
5.2.1 Cognex Profile
5.2.2 Cognex Main Business
5.2.3 Cognex Pharmaceutical Traceability Products, Services and Solutions
5.2.4 Cognex Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.2.5 Cognex Recent Developments
5.3 Datalogic
5.3.1 Datalogic Profile
5.3.2 Datalogic Main Business
5.3.3 Datalogic Pharmaceutical Traceability Products, Services and Solutions
5.3.4 Datalogic Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.3.5 Impinj Recent Developments
5.4 Impinj
5.4.1 Impinj Profile
5.4.2 Impinj Main Business
5.4.3 Impinj Pharmaceutical Traceability Products, Services and Solutions
5.4.4 Impinj Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.4.5 Impinj Recent Developments
5.5 Zebra Technologies
5.5.1 Zebra Technologies Profile
5.5.2 Zebra Technologies Main Business
5.5.3 Zebra Technologies Pharmaceutical Traceability Products, Services and Solutions
5.5.4 Zebra Technologies Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.5.5 Zebra Technologies Recent Developments
5.6 Adents
5.6.1 Adents Profile
5.6.2 Adents Main Business
5.6.3 Adents Pharmaceutical Traceability Products, Services and Solutions
5.6.4 Adents Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.6.5 Adents Recent Developments
5.7 Alien Technology
5.7.1 Alien Technology Profile
5.7.2 Alien Technology Main Business
5.7.3 Alien Technology Pharmaceutical Traceability Products, Services and Solutions
5.7.4 Alien Technology Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.7.5 Alien Technology Recent Developments
5.8 AlpVision
5.8.1 AlpVision Profile
5.8.2 AlpVision Main Business
5.8.3 AlpVision Pharmaceutical Traceability Products, Services and Solutions
5.8.4 AlpVision Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.8.5 AlpVision Recent Developments
5.9 Atlantic Zeiser
5.9.1 Atlantic Zeiser Profile
5.9.2 Atlantic Zeiser Main Business
5.9.3 Atlantic Zeiser Pharmaceutical Traceability Products, Services and Solutions
5.9.4 Atlantic Zeiser Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.9.5 Atlantic Zeiser Recent Developments
5.10 Authentix
5.10.1 Authentix Profile
5.10.2 Authentix Main Business
5.10.3 Authentix Pharmaceutical Traceability Products, Services and Solutions
5.10.4 Authentix Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.10.5 Authentix Recent Developments
5.11 Axway
5.11.1 Axway Profile
5.11.2 Axway Main Business
5.11.3 Axway Pharmaceutical Traceability Products, Services and Solutions
5.11.4 Axway Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.11.5 Axway Recent Developments
5.12 Bar Code Integrators
5.12.1 Bar Code Integrators Profile
5.12.2 Bar Code Integrators Main Business
5.12.3 Bar Code Integrators Pharmaceutical Traceability Products, Services and Solutions
5.12.4 Bar Code Integrators Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.12.5 Bar Code Integrators Recent Developments
5.13 SATO VICINITY
5.13.1 SATO VICINITY Profile
5.13.2 SATO VICINITY Main Business
5.13.3 SATO VICINITY Pharmaceutical Traceability Products, Services and Solutions
5.13.4 SATO VICINITY Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.13.5 SATO VICINITY Recent Developments
5.14 SMARTRAC
5.14.1 SMARTRAC Profile
5.14.2 SMARTRAC Main Business
5.14.3 SMARTRAC Pharmaceutical Traceability Products, Services and Solutions
5.14.4 SMARTRAC Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.14.5 SMARTRAC Recent Developments
5.15 TraceLink
5.15.1 TraceLink Profile
5.15.2 TraceLink Main Business
5.15.3 TraceLink Pharmaceutical Traceability Products, Services and Solutions
5.15.4 TraceLink Pharmaceutical Traceability Revenue (US$ Million) & (2018-2023)
5.15.5 TraceLink Recent Developments
6 North America
6.1 North America Pharmaceutical Traceability Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Traceability Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Traceability Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Traceability Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Traceability Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Traceability Market Dynamics
11.1 Pharmaceutical Traceability Industry Trends
11.2 Pharmaceutical Traceability Market Drivers
11.3 Pharmaceutical Traceability Market Challenges
11.4 Pharmaceutical Traceability Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’